D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 81 Citations 35,893 148 World Ranking 2396 National Ranking 1297

Research.com Recognitions

Awards & Achievements

2019 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Enzyme
  • Cancer

Nissim Hay mainly focuses on Cell biology, Protein kinase B, PI3K/AKT/mTOR pathway, Cancer cell and Kinase. His Cell biology research is multidisciplinary, relying on both Hexokinase, Programmed cell death and Carcinogenesis. His Protein kinase B study frequently draws connections between adjacent fields such as Mitochondrion.

His PI3K/AKT/mTOR pathway study frequently draws connections between related disciplines such as Phosphorylation. The study incorporates disciplines such as Oxidative stress, Carbohydrate metabolism, Pentose phosphate pathway and Cancer research in addition to Cancer cell. The various areas that Nissim Hay examines in his Cancer research study include Lung cancer, Breast cancer and Tumor initiation.

His most cited work include:

  • Upstream and downstream of mTOR (3385 citations)
  • The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. (993 citations)
  • The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. (820 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Protein kinase B, Cancer research, Cell biology, PI3K/AKT/mTOR pathway and AKT1. Nissim Hay interconnects Molecular biology and Kinase in the investigation of issues within Protein kinase B. His work deals with themes such as Cancer cell, Cancer, Carcinogenesis, Apoptosis and PTEN, which intersect with Cancer research.

His Cell biology research incorporates elements of Biochemistry and Programmed cell death. The concepts of his PI3K/AKT/mTOR pathway study are interwoven with issues in Platelet activation and Effector. His research integrates issues of Platelet, Internal medicine, Endocrinology and Cyclin D1 in his study of AKT1.

He most often published in these fields:

  • Protein kinase B (61.54%)
  • Cancer research (57.69%)
  • Cell biology (44.87%)

What were the highlights of his more recent work (between 2017-2021)?

  • Cancer research (57.69%)
  • Protein kinase B (61.54%)
  • Glycolysis (12.18%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Cancer research, Protein kinase B, Glycolysis, Metastasis and Cell biology. Nissim Hay combines subjects such as Cancer, Cancer metabolism and Programmed cell death with his study of Cancer research. His work in Cancer addresses issues such as Phosphorylation, which are connected to fields such as Kinase.

Nissim Hay specializes in Protein kinase B, namely AKT2. His Glycolysis research is multidisciplinary, incorporating perspectives in Oxidative phosphorylation and Glucokinase. His work on Serine as part of his general Cell biology study is frequently connected to Glutaminase, thereby bridging the divide between different branches of science.

Between 2017 and 2021, his most popular works were:

  • Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin. (136 citations)
  • Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin. (136 citations)
  • Quantitative Lipid Imaging Reveals a New Signaling Function of Phosphatidylinositol-3,4-Bisphophate: Isoform- and Site-Specific Activation of Akt. (38 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Enzyme
  • Cancer

Cell biology, Cancer research, Hexokinase, Oxidative phosphorylation and Glycolysis are his primary areas of study. His work on AKT2, Protein kinase B and Metabolic Stress as part of general Cell biology study is frequently linked to Nutrient stress, bridging the gap between disciplines. His biological study focuses on AKT1.

His Cancer research study combines topics from a wide range of disciplines, such as Inflammation, Transfection and Arthritis. His Hexokinase research is multidisciplinary, incorporating elements of mTORC1, Gene silencing, Glucokinase and Programmed cell death. His work carried out in the field of Glycolysis brings together such families of science as Glycine, Citric acid cycle, Serine and Biosynthesis.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Upstream and downstream of mTOR

Nissim Hay;Nahum Sonenberg.
Genes & Development (2004)

5043 Citations

The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal.

Scott G. Kennedy;Andrew J. Wagner;Suzanne D. Conzen;Joaquin Jordan.
Genes & Development (1997)

1353 Citations

Growth retardation and increased apoptosis in mice with homozygous disruption of the akt1 gene

William S. Chen;Pei Zhang Xu;Kathrin Gottlob;Mei Ling Chen.
Genes & Development (2001)

1160 Citations

The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB.

Eugene S. Kandel;Nissim Hay.
Experimental Cell Research (1999)

1134 Citations

4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway

Anne Claude Gingras;Scott G. Kennedy;Maura A. O'Leary;Nahum Sonenberg.
Genes & Development (1998)

1093 Citations

Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase

Kathrin Gottlob;Nathan Majewski;Scott Kennedy;Scott Kennedy;Eugene Kandel.
Genes & Development (2001)

1019 Citations

Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2

Xiao ding Peng;Pei Zhang Xu;Mei Ling Chen;Annett Hahn-Windgassen.
Genes & Development (2003)

940 Citations

The two TORCs and Akt.

Prashanth T. Bhaskar;Nissim Hay.
Developmental Cell (2007)

928 Citations

AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress

Sang Min Jeon;Navdeep S. Chandel;Nissim Hay.
Nature (2012)

882 Citations

The Akt-mTOR tango and its relevance to cancer.

Nissim Hay.
Cancer Cell (2005)

852 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Nissim Hay

Leonidas C. Platanias

Leonidas C. Platanias

Northwestern University

Publications: 109

Nahum Sonenberg

Nahum Sonenberg

McGill University

Publications: 98

Brian A. Hemmings

Brian A. Hemmings

Friedrich Miescher Institute

Publications: 59

Morris J. Birnbaum

Morris J. Birnbaum

Pfizer (United States)

Publications: 48

Craig B. Thompson

Craig B. Thompson

Memorial Sloan Kettering Cancer Center

Publications: 42

Gordon B. Mills

Gordon B. Mills

Oregon Health & Science University

Publications: 40

Jeffrey C. Rathmell

Jeffrey C. Rathmell

Vanderbilt University Medical Center

Publications: 37

Gerard I. Evan

Gerard I. Evan

The Francis Crick Institute

Publications: 36

Navdeep S. Chandel

Navdeep S. Chandel

Northwestern University

Publications: 35

Peter Carmeliet

Peter Carmeliet

KU Leuven

Publications: 35

David M. Sabatini

David M. Sabatini

MIT

Publications: 33

Ralph J. DeBerardinis

Ralph J. DeBerardinis

The University of Texas Southwestern Medical Center

Publications: 33

Benoit Viollet

Benoit Viollet

Institut Cochin

Publications: 33

Kenneth Walsh

Kenneth Walsh

University of Virginia

Publications: 33

Richard G. Pestell

Richard G. Pestell

The Wistar Institute

Publications: 32

Linda Z. Penn

Linda Z. Penn

University of Toronto

Publications: 32

Trending Scientists

Abdallah Shami

Abdallah Shami

Western University Canada

Hanmin Huang

Hanmin Huang

University of Science and Technology of China

Alexander Deiters

Alexander Deiters

University of Pittsburgh

Jeffery L. Yarger

Jeffery L. Yarger

Arizona State University

Douglas S. Clark

Douglas S. Clark

University of California, Berkeley

Piet Herdewijn

Piet Herdewijn

KU Leuven

Suzanne L. Strom

Suzanne L. Strom

Western Washington University

Rients E. Niks

Rients E. Niks

Wageningen University & Research

J. Joshua Smith

J. Joshua Smith

Memorial Sloan Kettering Cancer Center

Elizabeth S. Williams

Elizabeth S. Williams

University of Wyoming

Andreas Fichtner

Andreas Fichtner

ETH Zurich

Bruce D. Malamud

Bruce D. Malamud

King's College London

Theodore P. Beauchaine

Theodore P. Beauchaine

The Ohio State University

Scott D. Gest

Scott D. Gest

University of Virginia

Hakan Oral

Hakan Oral

University of Michigan–Ann Arbor

Rasmus Handberg

Rasmus Handberg

Aarhus University

Something went wrong. Please try again later.